Outlook Therapeutics Stock Discussion

$Outlook Therapeutics (OTLK.US)$ Outlook Therapeutics® to Present at the Guggenheim Healthcare Innovation Conference 11/12/2024
6 MINUTES AGO, 8:05 AM EST
VIA GLOBENEWSWIRE

$Outlook Therapeutics (OTLK.US)$ Reuters · 1 min ago                           Outlook Therapeutics® Announces UK Mhra Marketing Authorization of Lytenava™ (Bevacizumab Gamma) for the Treatment of Wet AMD

$Outlook Therapeutics (OTLK.US)$
Outlook Therapeutics® Receives European Commission Marketing Authorization for LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD
Outlook Therapeutics has received European Commission Marketing Authorization for LYTENAVA™ (bevacizumab gamma), an ophthalmic formulation for treating wet AMD. This makes it the first ophthalmic bevacizumab formulation approved for wet AMD in the EU. This authorization covers all 27 EU Member States and will extend to Icela...

$Outlook Therapeutics (OTLK.US)$ Outlook Therapeutics® Announces UK Submission of Marketing Authorization Application (Maa) for Ons-5010 as a Treatment for Wet AMD

$Outlook Therapeutics (OTLK.US)$ Outlook Therapeutics® Announces Closing of Private Placement of $5.0 Million

$Outlook Therapeutics (OTLK.US)$ Just keep slowly walking up up up! been a nice uptrend for a few days now!

$Outlook Therapeutics (OTLK.US)$ BTIG Upgrades Outlook Therapeutics to Buy, Announces $50 Price Target

$Outlook Therapeutics (OTLK.US)$ 10 dollars